Our findings demonstrate that EPO-BM-MSCs rescue epithelial cell injury by mitochondrial donation by upregulating HO-1 to alleviate asthma inflammation, providing novel evidence for the therapeutic potential of EPO-BM-MSCs in asthma. Here, HMOX1 is linked to asthma.